{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:59:23Z","timestamp":1784329163922,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1997,9,1]],"date-time":"1997-09-01T00:00:00Z","timestamp":873072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1997,9]]},"DOI":"10.1007\/s002130050184","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T07:47:25Z","timestamp":1030261645000},"page":"225-232","source":"Crossref","is-referenced-by-count":23,"title":["Nicotinic acetylcholine receptor (nACh-R) agonist-induced changes in brain monoamine turnover in mice"],"prefix":"10.1007","volume":"129","author":[{"given":"Yoshihiro","family":"Tani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Tsuneyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Imoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomochika","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"71290225213_CR1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0304-3940(89)90837-9","volume":"107","author":"A Adem","year":"1989","unstructured":"Adem A, Jossan SS, Oreland L (1989) Tetrahydroaminoacridine inhibits human and rat brain monoamine oxidase. Neurosci Lett 107:313\u2013317","journal-title":"Neurosci Lett"},{"key":"71290225213_CR2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-2999(94)90200-3","volume":"253","author":"DJ Anderson","year":"1994","unstructured":"Anderson DJ, Arneric SP (1994) Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain. Eur J Pharmacol 253:261\u2013267","journal-title":"Eur J Pharmacol"},{"key":"71290225213_CR3","first-page":"27","volume":"479","author":"K Andersson","year":"1979","unstructured":"Andersson K, Fuxe K, Eneroth P, Gustafsson J-A, Agnati LF (1979) Mecamylamine induced blockade of nicotine induced inhibition of gonadotopin an TSH secretion and nicotine induced increases of catecholamine turn over in rat hypothalamus. Acta Physiol Scand 479:27\u201329","journal-title":"Acta Physiol Scand"},{"key":"71290225213_CR4","first-page":"310","volume":"270","author":"SP Arneric","year":"1994","unstructured":"Arneric SP, Sullivan JP, Briggs CA, Donnelly-Roberts D, Anderson DJ, Raszkiewiez JL, Huges ML, Cadman ED, Adams P, Garvey DS, Wasicak JT, Williams M (1994) (S)-3-Methyl-5-(l-methyl-2-pyrrolidinyl)isoxazole (ABT-418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. in vitro characterization. J Pharmacol Exp Ther 270:310\u2013318","journal-title":"J Pharmacol Exp Ther"},{"key":"71290225213_CR5","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.1073\/pnas.84.21.7763","volume":"84","author":"J Boulter","year":"1987","unstructured":"Boulter J, Connolly J, Deneris E, Goldman D, Heinemann S, Patrick J (1987) Functional expression of two neural nicotinic acetylcholine receptors from cDNA clones identifies a gene family. Proc Natl Acad Sci USA 84:7763\u20137767","journal-title":"Proc Natl Acad Sci USA"},{"key":"71290225213_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(94)90002-7","volume":"643","author":"JD Brioni","year":"1994","unstructured":"Brioni JD, Kim DJB, O\u2019Neill AB, Williams JEG, Decker MW (1994) Clozapine attenuates the discriminative stimulus properties of ( \u2212)nicotine. Brain Res 643:1\u20139","journal-title":"Brain Res"},{"key":"71290225213_CR7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0006-8993(94)91721-3","volume":"667","author":"JA Court","year":"1994","unstructured":"Court JA, Perry EK, Spurden D, Lloyd S, Gillespie JI, Whiting P, Barlow R (1994) Comparison of the binding of nicotinic agonists to receptors from human and rat cerebral cortex and from chick brain (\u03b14\u03b22) transfected into mouse fibroblasts with ion channel activity. Brain Res 667:118\u2013122","journal-title":"Brain Res"},{"key":"71290225213_CR8","doi-asserted-by":"crossref","first-page":"17560","DOI":"10.1016\/S0021-9258(18)38201-2","volume":"265","author":"S Couturier","year":"1990","unstructured":"Couturier S, Erkman L, Valera S, Rungger D, Bertrand S, Boulter J, Ballivet M, Bertrand D (1990) \u03b15, \u03b13 and non-\u03b13: three clustered avian genes encoding neuronal nicotinic acetylcholine receptor releated subunits. J Biol Chem 265: 17560\u201317567","journal-title":"J Biol Chem"},{"key":"71290225213_CR9","first-page":"319","volume":"270","author":"MW Decker","year":"1994","unstructured":"Decker MW, Brioni JD, Sullivan JP, Buckley MJ, Radek RJ, Raszkiewiez JL, Kang LH, Kim DJB, Giardina WJ, Wasicak JT, Garvey DS, Williams M, Arneric SP (1994) (S)-3-Methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. in vitro characterization. J Pharmacol Exp Ther 270: 319\u2013328","journal-title":"J Pharmacol Exp Ther"},{"key":"71290225213_CR10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0024-3205(94)00488-E","volume":"56","author":"MW Decker","year":"1995","unstructured":"Decker MW, Brioni JD, Bannon AW, Arneric SP (1995) Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. Life Sci 56:545\u2013570","journal-title":"Life Sci"},{"key":"71290225213_CR11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(87)90424-9","volume":"141","author":"B Drukarch","year":"1987","unstructured":"Drukarch B, Kits KS, Van Der Meer EG, Lodder JC, Stoof JC (1987) 9-Amino-l,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer\u2019s disease, inhibits acetylcholine esterase activity and slow outward K+ current. Eur J Pharmacol 141:153\u2013157","journal-title":"Eur J Pharmacol"},{"key":"71290225213_CR12","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0024-3205(88)90431-6","volume":"42","author":"B Drukarch","year":"1988","unstructured":"Drukarch B, Leysen JE, Stoof JG (1988) Further analysis of the neuropharmacological profile of 9-amino-l,2,3,4-tetrahy-droacridine (THA), an alleged drug for the treatment of Alzheimer\u2019s disease. Life Sci 42:1011\u20131017","journal-title":"Life Sci"},{"key":"71290225213_CR13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0092-8674(94)90555-X","volume":"79","author":"AB Elgoyhen","year":"1994","unstructured":"Elgoyhen AB, Johnson DS, Boulter J, Vetter DE, Heinemann S (1994) \u03b19: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79:705\u2013715","journal-title":"Cell"},{"key":"71290225213_CR14","first-page":"31","volume":"41","author":"CM Flores","year":"1992","unstructured":"Flores CM, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is upregulated by chronic nicotine treatment. Mol Pharmacol 41:31\u201337","journal-title":"Mol Pharmacol"},{"key":"71290225213_CR15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0091-3057(79)90319-8","volume":"10","author":"K Fuxe","year":"1979","unstructured":"Fuxe K, Everitt BJ, H\u00f6kfelt T (1979) On the action of nicotine and cotinine on central 5-hydroxy-tryptamine neurons. Pharmacol Biochem Behav 10:671\u2013677","journal-title":"Pharmacol Biochem Behav"},{"key":"71290225213_CR16","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1021\/jm00034a002","volume":"37","author":"DS Garvey","year":"1994","unstructured":"Garvey DS, Wasicak J, Decker MW, Brioni JD, Sullivan JP, Carrera GM, Holladay MH, Arneric SP, Williams M (1994) Novel isoxazoles which interact with brain cholinergic channel receptors that have intrinsic cognitive enhancing and anxiolytic activities. J Med Chem 37: 1055\u20131059","journal-title":"J Med Chem"},{"key":"71290225213_CR17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1471-4159.1992.tb08322.x","volume":"59","author":"S Grady","year":"1992","unstructured":"Grady S, Marks MJ, Wonnacott S, Collins AC (1992) Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 59:848\u2013856","journal-title":"J Neurochem"},{"key":"71290225213_CR18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00451686","volume":"98","author":"JJ Hagan","year":"1989","unstructured":"Hagan JJ, Jansen JHM, Broekkamp CLM (1989) Hemicholinium-3 impairs spatial learning and the deficit is reversed by cholinomimetics. Psychopharmacology 98:347\u2013356","journal-title":"Psychopharmacology"},{"key":"71290225213_CR19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1476-5381.1989.tb11852.x","volume":"96","author":"DJ Heal","year":"1989","unstructured":"Heal DJ, Prow MR, Buckett WR (1989) Measurement of 3-methoxy-4-hydroxyphenylglycol (MHPG) in mouse brain by h.p.l.c. with electrochemical detection, as an index of noradrenaline utilisation and presynaptic \u03b12-adrenoceptor function. Br J Pharmacol 96:547\u2013556","journal-title":"Br J Pharmacol"},{"key":"71290225213_CR20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0014-2999(86)90629-1","volume":"132","author":"A Imperato","year":"1986","unstructured":"Imperato A, Mulas A, Dichiara G (1986) Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 132:337\u2013338","journal-title":"Eur J Pharmacol"},{"key":"71290225213_CR21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/BF02247426","volume":"108","author":"GMM Jones","year":"1992","unstructured":"Jones GMM, Sahakian BJ, Levy R, Warburnton DM, Gray JA (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer\u2019s disease. Psychopharmacology 108:485\u2013494","journal-title":"Psychopharmacology"},{"key":"71290225213_CR22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1248\/bpb1978.12.107","volume":"12","author":"T Kubo","year":"1989","unstructured":"Kubo T, Amano H, Kurahashi K, Misu Y (1989) Nicotine-induced regional changes in brain noradrenaline and dopamine turnover in rats. J Pharmacobiodyn 12:107\u2013112","journal-title":"J Pharmacobiodyn"},{"key":"71290225213_CR23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF02247415","volume":"108","author":"ED Levin","year":"1992","unstructured":"Levin ED (1992) Nicotinic systems and cognitive function. Psychopharmacology 108:417\u2013431","journal-title":"Psychopharmacology"},{"key":"71290225213_CR24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ddr.430310106","volume":"31","author":"ED Levin","year":"1994","unstructured":"Levin ED, Eisner B (1994) Nicotine interactions with dopamine agonists: effects on working memory function. Drug Dev Res 31:32\u201337","journal-title":"Drug Dev Res"},{"key":"71290225213_CR25","first-page":"542","volume":"264","author":"MJ Marks","year":"1993","unstructured":"Marks MJ, Farnham DA, Grady SR, Collins AC (1993) Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes. J Pharmacol Exp Ther 264:542\u2013552","journal-title":"J Pharmacol Exp Ther"},{"key":"71290225213_CR26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ddr.430310207","volume":"31","author":"EM Meyer","year":"1994","unstructured":"Meyer EM, deFiebre CM, Hunter BE, Simpkins CE, Fraumorth N, deFiebre NEC (1994) Effects of anabaseine-related analoges on rat brain nicotinic receptor binding and on avoidance behaviors. Drug Dev Res 31:127\u2013134","journal-title":"Drug Dev Res"},{"key":"71290225213_CR27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0006-8993(89)91518-7","volume":"478","author":"J-C Mifsud","year":"1989","unstructured":"Mifsud J-C, Hernandez L, Hoebel BG (1989) Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis. Brain Res 478:365\u2013367","journal-title":"Brain Res"},{"key":"71290225213_CR28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0024-3205(79)90212-1","volume":"24","author":"WW Morgan","year":"1979","unstructured":"Morgan WW, Pfeil KA (1979) Mecamylamine blockade of nicotine enhanced noradrenaline turnover in rat brain. Life Sci 24:417\u2013420","journal-title":"Life Sci"},{"key":"71290225213_CR29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/j.1460-2075.1988.tb02852.x","volume":"7","author":"P Nef","year":"1988","unstructured":"Nef P, Oneyser C, Alliod C, Couturier S, Ballivet M (1988) Genes expressed in the brain define three distinct neuronal nicotinic acetylcholine receptors. EMBO J 7:595\u2013601","journal-title":"EMBO J"},{"key":"71290225213_CR30","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1176\/ajp.143.11.1494","volume":"143","author":"PA Newhouse","year":"1986","unstructured":"Newhouse PA, Sunderland T, Thompson K, Tariot PN, Weingartner H, Mueller ER, Cohen RM, Murphy DL (1986) Intravenous nicotine in patient with Alzheimer\u2019s disease. Am J Psychiatry 143:1494\u20131495","journal-title":"Am J Psychiatry"},{"key":"71290225213_CR31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/npp.1994.11","volume":"10","author":"PA Newhouse","year":"1994","unstructured":"Newhouse PA, Potter A, Corwin J, Lenox R (1994) Age-related effects of the nicotine antagonist mecamylamine on cognition and behavior. Neuropsychopharmacology 10:93\u2013107","journal-title":"Neuropsychopharmacology"},{"key":"71290225213_CR32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/syn.890160105","volume":"16","author":"M Nisell","year":"1994","unstructured":"Nisell M, Nomikos GG, Svenssin TH (1994) Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 16:36\u201344","journal-title":"Synapse"},{"key":"71290225213_CR33","first-page":"9","volume":"39","author":"LA Pabreza","year":"1990","unstructured":"Pabreza LA, Dhawan S, Kellar KJ (1990) [3H]Cytisine binding to nicotinic cholinergic receptors in brain. Mol Pharmacol 39:9\u201312","journal-title":"Mol Pharmacol"},{"key":"71290225213_CR34","first-page":"142","volume":"45","author":"RL Papke","year":"1994","unstructured":"Papke RL, Heinemann SF (1994) Partial agonist properties of cyti-sine on neuronal nicotinic receptors containing the \u03b22 subunit. Mol Pharmacol 45:142\u2013149","journal-title":"Mol Pharmacol"},{"key":"71290225213_CR35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/BF00439274","volume":"81","author":"J Pratt","year":"1983","unstructured":"Pratt J, Stolerman I, Garcha H, Giardini V, Feyerabend C (1983) Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor. Psychopharmacology 81:54\u201360","journal-title":"Psychopharmacology"},{"key":"71290225213_CR36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0006-8993(93)90121-3","volume":"621","author":"EB Ribeiro","year":"1993","unstructured":"Ribeiro EB, Bettiker RL, Bogdanov M, Wurtman RJ (1993) Effects of systemic nicotine on serotonin release in rat brain. Brain Res 621:311\u2013318","journal-title":"Brain Res"},{"key":"71290225213_CR37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0006-8993(93)90812-2","volume":"622","author":"M Riekkinen","year":"1993","unstructured":"Riekkinen M, Sirvio J, Riekkinen Jr P (1993) Pharmacological consequences of nicotinergic plus serotonergic manipulations. Brain Res 622:139\u2013146","journal-title":"Brain Res"},{"key":"71290225213_CR38","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/j.1476-5381.1989.tb12656.x","volume":"98","author":"TN Robinson","year":"1989","unstructured":"Robinson TN, De Souza RJ, Cross AJ, Green AR (1989) The mechanism of tetrahydroaminoacridine-evoked release of endogenous 5-hydroxytryptamine and dopamine from rat brain tissue prisms. Br J Pharmacol 98:1127\u20131136","journal-title":"Br J Pharmacol"},{"key":"71290225213_CR39","first-page":"416","volume":"221","author":"KA Roth","year":"1982","unstructured":"Roth KA, Stecen LM, Barchas JD (1982) Nicotinic-catecholamin-ergic interactions in rat brain: evidence for cholinergic nicotinic and muscarinic interactions with hypothalamic epinephrine. J Pharmacol Exp Ther 221:416\u2013420","journal-title":"J Pharmacol Exp Ther"},{"key":"71290225213_CR40","first-page":"224","volume":"274","author":"AI Sacaan","year":"1995","unstructured":"Sacaan AI, Dunlop JL, Lloyd GK (1995) Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J Pharmacol Exp Ther 274:224\u2013230","journal-title":"J Pharmacol Exp Ther"},{"key":"71290225213_CR41","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1192\/bjp.154.6.797","volume":"154","author":"B Sahakian","year":"1989","unstructured":"Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of Alzheimer\u2019s type. Br J Psychiatry 154:797\u2013800","journal-title":"Br J Psychiatry"},{"key":"71290225213_CR42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1210\/endo.133.1.8391419","volume":"133","author":"BM Sharp","year":"1993","unstructured":"Sharp BM, Matta SG (1993) Detection by in vivo microdialysis of nicotine-induced norepinephrine secretion from the hypothalamic paraventricular nucleus of freely moving rats: dose-dependency and desensitization. Endocrinology 133: 11\u201319","journal-title":"Endocrinology"},{"key":"71290225213_CR43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF00555223","volume":"84","author":"I Stolerman","year":"1984","unstructured":"Stolerman I, Garcha H, Pratt J, Kumar R (1984) Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology 84:413\u2013419","journal-title":"Psychopharmacology"},{"key":"71290225213_CR44","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0024-3205(90)90017-L","volume":"46","author":"Y Tani","year":"1990","unstructured":"Tani Y, Ishihara T (1990) Simultaneous measurement of tetrahy-drobiopterin (THBP) and biogenic amines by liquid chromatography with electrochemical detection. Life Sci 46: 373\u2013378","journal-title":"Life Sci"},{"key":"71290225213_CR45","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.2832952","volume":"240","author":"K Wada","year":"1988","unstructured":"Wada K, Ballivet M, Boulter J, Connolly J, Wada E, Deneris E, Swanson L, Heinemann S, Patrick J (1988) Functional expression of a new pharmacological subtype of brain nicotinic acetylcholine receptors. Science 240:330\u2013334","journal-title":"Science"},{"key":"71290225213_CR46","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0028-3908(74)90015-X","volume":"13","author":"TC Westfall","year":"1974","unstructured":"Westfall TC (1974) Effect of nicotine and other drugs on the release of 3H-norepinephrine and 3H-dopamine from rat brain slices. Neuropharmacology 13:693\u2013700","journal-title":"Neuropharmacology"},{"key":"71290225213_CR47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0006-8993(80)91194-4","volume":"182","author":"K Yoshida","year":"1980","unstructured":"Yoshida K, Kato Y, Imura H (1980) Nicotine-induced release of noradrenaline from hypothalamic synaptosomes. Brain Res 182:361\u2013368","journal-title":"Brain Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s002130050184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s002130050184\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s002130050184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T11:05:09Z","timestamp":1620039909000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s002130050184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,9]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,9]]}},"alternative-id":["71290225213"],"URL":"https:\/\/doi.org\/10.1007\/s002130050184","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,9]]}}}